Opportunistic Infections  Citation List: 

September 2, 2009 – September 15, 2009

OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])

1. Effects of curcumin on Cryptosporidium parvum in vitro.

Shahiduzzaman M, Dyachenko V, Khalafalla RE, Desouky AY, Daugschies A.

Parasitol Res. 2009 Oct;105(4):1155-61. Epub 2009 Jun 26.

PMID: 19557435 [PubMed - in process]

ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

2. Isolation and characterization of a French bean hemagglutinin with antitumor, antifungal, and anti-HIV-1 reverse transcriptase activities and an exceptionally high yield.

Lam SK, Ng TB.

Phytomedicine. 2009 Sep 7. [Epub ahead of print]

PMID: 19740639 [PubMed - as supplied by publisher]

3. Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans.

Lu SE, Novak J, Austin FW, Gu G, Ellis D, Kirk M, Wilson-Stanford S, Tonelli M, Smith L.

Biochemistry. 2009 Sep 8;48(35):8312-21.

PMID: 19673482 [PubMed - in process]

4. Biological Activities of Pyrazoline Derivatives -A Recent Development.

Kumar S, Bawa S, Drabu S, Kumar R, Gupta H.

Recent Pat Antiinfect Drug Discov. 2009 Nov 1. [Epub ahead of print]

PMID: 19545230 [PubMed - as supplied by publisher]

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp.,  Drug Resistant, MAC, MDR)

5. 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.

Starr JT, Sciotti RJ, Hanna DL, Huband MD, Mullins LM, Cai H, Gage JW, Lockard M, Rauckhorst MR, Owen RM, Lall MS, Tomilo M, Chen H, McCurdy SP, Barbachyn MR.

Bioorg Med Chem Lett. 2009 Sep 15;19(18):5302-6. Epub 2009 Aug 3.

PMID: 19683922 [PubMed - in process]

6. Braendvang, M., V. Bakken, and L.L. Gundersen, Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Bioorg Med Chem, 2009. 17(18): p. 6512-6; PMID[19709890] http://www.ncbi.nlm.nih.gov/pubmed/19709890?ordinalpos=105&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

7. Podust, L.M., H. Ouellet, J.P. von Kries, and P.R. Ortiz de Montellano, Interaction of Mycobacterium tuberculosis CYP130 with Heterocyclic Arylamines. J Biol Chem, 2009. 284(37): p. 25211-9; PMID[19605350] http://www.ncbi.nlm.nih.gov/pubmed/19605350?ordinalpos=124&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Citations from the ISI Web of  Knowledge Listings for  O.I.

8. Correia, C., et al

Synthesis and in vitro activity of 6-amino-2,9-diarylpurines for Mycobacterium tuberculosis
TETRAHEDRON  2009 (August 22) 65: 6903 – 6911

9. Khumkomkhet, P., et al

Antimalarial and Cytotoxic Depsidones from the Fungus Chaetomium brasiliense
JOURNAL OF NATURAL PRODUCTS  2009 (August) 72: 1487 – 1491

10. Kuete, V., et al

Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS  2009 (October) 34: 322 – 325

11. Vieira, LMM., et al

Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY  2009 (October) 44: 4107 – 4111

12. Wei, Y., et al

Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1 protease activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2009 (October) 44: 4112 - 4120

13. Aridoss, G., et al

Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on
t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY  2009 (October) 44: 4199 – 4210